Metabiomics: Prescient Metabiomics, CoreBiome collaborate to develop colon cancer screening test, LifeKit Prevent
Prescient Metabiomics, a privately held molecular diagnostics company, and CoreBiome, a microbiome genomics company, announced a collaboration to develop a new test called LifeKit Prevent, which may represent a microbiome─driven paradigm shift in colon cancer screening.
Read full article »
Metabiomics develops non-invasive diagnostics for colon polyps and colon cancer based on an interrogation of the human gut microbiome.
Read more